Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of LY4005130 in adults with nonsegmental vitiligo
CTR20262702Phase 2Active
- Sponsor
- Eli Lilly and Company
- Start
- Sep 2026
- Countries
- 1
01
Overview
A Phase 2 trial of LY4005130 in nonsegmental vitiligo, sponsored by Eli Lilly and Company. Started Sep 2026; status: active.
02
Drugs
LY4005130
03
Conditions
nonsegmental vitiligo
Beyond the preview
Go deeper on CTR20262702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262702.